Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2025-08-01 00:00:00 ET · period of report 2025-07-30 · accession 0000874015-25-000170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-01 | 2025-07-30 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $45.00 | -2,432 | 179.8K | -1% | -$109.4K |
| D | 2025-08-01 | 2025-07-30 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $32.60 | +2,432 | 182.3K | +1% | +$79.3K |
| D | 2025-08-01 | 2025-07-30 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $0.00 | -2,432 | 99.1K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-07-30 | S | D | 2,432 | $45.00 | 179,820 | D | — | — | (F1) Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 13, 2024. |
| 2 | Common | Common Stock | 2025-07-30 | M | A | 2,432 | $32.60 | 182,252 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-07-30 | M | D | 2,432 | $0.00 | 99,057 | D | $32.60 · 2023-01-03 to 2032-01-02 | 2,432 Common Stock |